W. Jonat

16.5k citations
297 papers · 9.8k · 3 hit papers · h-index 49

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Bone health and treatments
    • Cancer Risks and Factors

Papers in

    • Estrogen and related hormone effects 65
    • Breast Cancer Treatment Studies 58
    • Protease and Inhibitor Mechanisms 12

W. Jonat

279 papers receiving 9.4k citations

W. Jonat's Hit Papers

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer 2009 · 504 citations
5040+7+14Years since publication200400600

Peers

W. Jonat
Comparison fields: 5 of 152
  • Cancer Research 2.9k
  • Oncology 3.5k
  • Genetics 2.8k
  • Reproductive Medicine 760
  • Obstetrics and Gynecology 508
Replace Christian Marth with:
Christian Marth Austria
R. Kreienberg Germany
Peggy L. Porter United States
J. Michael Dixon United Kingdom
Marianna Zahurak United States
Patrice Watson United States
T. Tong United States
Marion Kiechle Germany
Judith R. Kroep Netherlands
Massimo Aglietta Italy
W. Jonat relative to Christian Marth Austria Christian Marth's profile →
Citations per field
00.5×1.5×2.0×
Christian Marth · 1×
Citations per year

Countries citing papers authored by W. Jonat

Since Specialization
Citations

This map shows the geographic impact of W. Jonat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jonat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jonat more than expected).

Fields of papers citing papers by W. Jonat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Jonat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jonat. The network helps show where W. Jonat may publish in the future.

Co-authors

The 25 scholars most cited alongside W. Jonat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Jonat Line = papers co-authored together W. Jonat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 297 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Hit paper breakdown →
2005645
2
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
Hit paper breakdown →
2006548
3
Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
Hit paper breakdown →
2009504
4 2007348
5
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
1998340
6 1996298
7 2002245
8 1996207
9 2003203
10 2007191
11 1993188
12 2004155
13 2006150
14
Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
2001144
15 2015143
16 1998143
17 1998129
18 2005128
19 1998120
20 2013117

About W. Jonat

W. Jonat is a scholar working on Genetics, Cancer Research, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 297 papers that have together received 9.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (65 papers), Breast Cancer Treatment Studies (58 papers), Cancer Treatment and Pharmacology (28 papers), HER2/EGFR in Cancer Research (22 papers), Advanced Breast Cancer Therapies (16 papers), Ovarian cancer diagnosis and treatment (15 papers), Prenatal Screening and Diagnostics (14 papers) and Protease and Inhibitor Mechanisms (12 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (3.5k citations), Genetics (2.8k citations), Reproductive Medicine (760 citations) and Obstetrics and Gynecology (508 citations). W. Jonat has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include W. Eiermann, Manfred Kaufmann, Christoph Mundhenke, Anthony Howell, Nicolaì Maass, Michael Gnant, Carl Blomqvist, Gϋnter von Minckwitz, Liselotte Mettler and İbrahim Alkatout. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Archives of Gynecology and Obstetrics, Journal of Cancer Research and Clinical Oncology and Fertility and Sterility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact